Pathstone Holdings
GMAB icon

Pathstone Holdings’s Genmab GMAB Stock Holding History

Pathstone Holdings’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$559K Sell
20,348
-3,380
-14% -$89.8K ﹤0.01% 1817
2026
Q1 		$637K Buy
23,728
+2,218
+10% +$66.5K ﹤0.01% 1633
2025
Q4 		$663K Buy
21,510
+1,803
+9% +$56.2K ﹤0.01% 1622
2025
Q3 		$604K Buy
19,707
+5,705
+41% +$139K ﹤0.01% 1678
2025
Q2 		$289K Sell
14,002
-1,397
-9% -$28.7K ﹤0.01% 1940
2025
Q1 		$302K Sell
15,399
-7,090
-32% -$149K ﹤0.01% 1930
2024
Q4 		$469K Buy
22,489
+7,489
+50% +$165K ﹤0.01% 1744
2024
Q3 		$366K Buy
15,000
+4,940
+49% +$132K ﹤0.01% 1882
2024
Q2 		$253K Sell
10,060
-165
-2% -$4.68K ﹤0.01% 2029
2024
Q1 		$306K Sell
10,225
-500
-5% -$14.7K ﹤0.01% 1938
2023
Q4 		$341K Buy
+10,725
New +$337K ﹤0.01% 1741

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Pathstone Holdings's GMAB Position: Q2 2026 in Review

Pathstone Holdings reduced its Genmab (GMAB) stake by 14% in Q2 2026, selling an estimated $89.8K and leaving 20,348 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #1817.

Pathstone Holdings first reported a position in GMAB in Q4 2023 and has held it in 11 quarters since. The position peaked at $663K in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Pathstone Holdings held 20,348 shares of Genmab worth $559K as of Q2 2026.
  • Pathstone Holdings sold 3,380 Genmab shares in Q2 2026, an estimated $89.8K.
  • Genmab made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1817 holding.
  • Pathstone Holdings first reported a position in Genmab in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Genmab position peaked at $663K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.